Medicare Enrolled
Dr. David Aliabadi, M.D.
Interventional Cardiology · Thousand Oaks, CA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aliabadi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aliabadi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aliabadi
Dr. David Aliabadi is an interventional cardiology specialist in Thousand Oaks, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Aliabadi performed 11,838 Medicare services across 8,350 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aliabadi received a total of $12,141 from 47 pharmaceutical and/or device companies across 719 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aliabadi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in CA
$12,141 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,838
Medicare services
Top 6% in CA for interventional cardiology
8,350
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~592 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,010 | $99 | $176 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
2,281 | $12 | $70 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,033 | $74 | $140 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
932 | $40 | $88 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
732 | $171 | $820 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
465 | $167 | $375 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 438 | $407 | $1,100 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
394 | $62 | $404 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
277 | $147 | $227 |
| New patient office visit, complex (60-74 min) | 264 | $162 | $300 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
225 | $65 | $121 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
224 | $11 | $50 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
224 | $19 | $55 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
214 | $1,342 | $2,400 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
206 | $65 | $105 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
144 | $41 | $120 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
126 | $98 | $130 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
112 | $76 | $185 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
106 | $46 | $125 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
106 | $22 | $150 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
103 | $197 | $650 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
99 | $47 | $76 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
56 | $393 | $1,020 |
| Ultrasound of abdominal aorta An imaging test that uses sound waves to create pictures of the abdominal aorta, the large blood vessel that carries blood from the heart to the lower body. |
33 | $122 | $200 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
17 | $79 | $250 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $143 | $260 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.0% high complexity
20.5% medium
70.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,141
Total received (2018-2024)
Avg $1,734/year across 7 years
Top 35% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
719
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,141 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,642
2023
$1,803
2022
$2,166
2021
$2,256
2020
$1,700
2019
$1,700
2018
$875
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$251
Amgen Inc.
$191
AstraZeneca Pharmaceuticals LP
$180
Kiniksa Pharmaceuticals International, plc
$175
E.R. Squibb & Sons, L.L.C.
$163
PFIZER INC.
$155
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$98
Novartis Pharmaceuticals Corporation
$66
Novo Nordisk Inc
$64
BIOTRONIK INC.
$63
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Medtronic, Inc.
$45
Lexicon Pharmaceuticals, Inc.
$29
Edwards Lifesciences Corporation
$27
Janssen Pharmaceuticals, Inc
$23
SANOFI-AVENTIS U.S. LLC
$23
Actelion Pharmaceuticals US, Inc.
$22
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 37.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,701
Novartis Pharmaceuticals Corporation
$1,151
AstraZeneca Pharmaceuticals LP
$1,056
Amarin Pharma Inc.
$861
E.R. Squibb & Sons, L.L.C.
$830
Boehringer Ingelheim Pharmaceuticals, Inc.
$527
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$453
Novo Nordisk Inc
$414
Abbott Laboratories
$396
Janssen Pharmaceuticals, Inc
$388
Esperion Therapeutics, Inc.
$375
SANOFI-AVENTIS U.S. LLC
$355
Gilead Sciences, Inc.
$307
Boston Scientific Corporation
$305
Medtronic, Inc.
$280
Merck Sharp & Dohme LLC
$263
Edwards Lifesciences Corporation
$253
PFIZER INC.
$250
Medtronic Vascular, Inc.
$245
Kiniksa Pharmaceuticals, Ltd.
$205
Kiniksa Pharmaceuticals International, plc
$175
BIOTRONIK INC.
$152
Kowa Pharmaceuticals America, Inc.
$141
Merck Sharp & Dohme Corporation
$130
Itamar Medical Inc
$104
Actelion Pharmaceuticals US, Inc.
$94
Tactile Systems Technology Inc
$91
Regeneron Healthcare Solutions, Inc.
$71
iRhythm Technologies, Inc.
$65
ARBOR PHARMACEUTICALS, INC.
$58
Lundbeck LLC
$46
BOSTON SCIENTIFIC CORPORATION
$46
Allergan Inc.
$38
HeartFlow, Inc.
$36
Arbor Pharmaceuticals, Inc.
$32
Lexicon Pharmaceuticals, Inc.
$29
Alnylam Pharmaceuticals Inc.
$28
Kestra Medical Technology Services, Inc.
$24
CVRx, Inc.
$21
Relypsa, Inc.
$21
Biosense Webster, Inc.
$20
PORTOLA PHARMACEUTICALS, INC.
$20
Currax Pharmaceuticals LLC
$18
Astellas Pharma US Inc
$17
AngioDynamics, Inc.
$17
Baxter Healthcare
$15
Amryt Pharma Holdings Ltd
$15
Top 3 companies account for 32.2% of all-time payments
Associated products mentioned in payments ›
AMVIA EDGE · ANDEXXA · AZURE XT DR MRI SURESCAN · Accent Pacemaker · Arcalyst · Assure WCD · Azure · BIOMONITOR · BRILINTA · BYDUREON · BYSTOLIC · Barostim Neo System · CAMZYOS · COBALT DR MRI SURESCAN · CONTRAVE · COREVALVE EVOLUT R · Carto 3 · Claria MRI · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edora 8 DR-T · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FLEXITOUCH · Flexitouch Plus · General - Therapies · Hillrom - Cardiac Ambulatory Monitor · Horizant · JARDIANCE · JUXTAPID · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LIVALO · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · Ozempic · PAMIRA · PRADAXA · PRALUENT · RYBELSUS · Renamic Neo · Repatha · Rybelsus · SAPIEN 3 Ultra RESILIA · Saxenda · TEPEZZA · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WAINUA · WATCHMAN · WATCHMAN Access System · WatchPAT · WatchPATONE · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
32
Per 100K population
3.8
County median income
$107,327
Nearest hospital
LOS ROBLES HOSPITAL & MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aliabadi is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aliabadi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Aliabadi performed 3,010 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aliabadi receive payments from pharmaceutical companies?
Yes. Dr. Aliabadi received a total of $12,141 from 47 companies across 719 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aliabadi's costs compare to other interventional cardiologists in Thousand Oaks?
Dr. Aliabadi's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aliabadi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Thousand Oaks
Browse interventional cardiologists in Thousand Oaks ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology